Quaternary diagnostics scheme for mucolipidosis II and detection of novel mutation in GNPTAB gene

Abstract Background Mucolipidosis II (ML II α/β) is an inherited lysosomal storage disorder caused by deficiency of GlcNAc-phosphotransferase enzyme and results in mis-targeting of multiple lysosomal enzymes. Affected patients are characterized by skeletal deformities and developmental delay. Homozy...

Full description

Bibliographic Details
Main Authors: Mona L. Essawi, Ekram M. Fateen, Hanan A. Atia, Noura R. Eissa, Eman H. Aboul-Ezz, Mona M. Ibrahim, Heba A. Hassan, Samia A. Temtamy
Format: Article
Language:English
Published: Elsevier 2021-08-01
Series:Journal of Genetic Engineering and Biotechnology
Subjects:
Online Access:https://doi.org/10.1186/s43141-021-00204-4
_version_ 1797203703716904960
author Mona L. Essawi
Ekram M. Fateen
Hanan A. Atia
Noura R. Eissa
Eman H. Aboul-Ezz
Mona M. Ibrahim
Heba A. Hassan
Samia A. Temtamy
author_facet Mona L. Essawi
Ekram M. Fateen
Hanan A. Atia
Noura R. Eissa
Eman H. Aboul-Ezz
Mona M. Ibrahim
Heba A. Hassan
Samia A. Temtamy
author_sort Mona L. Essawi
collection DOAJ
description Abstract Background Mucolipidosis II (ML II α/β) is an inherited lysosomal storage disorder caused by deficiency of GlcNAc-phosphotransferase enzyme and results in mis-targeting of multiple lysosomal enzymes. Affected patients are characterized by skeletal deformities and developmental delay. Homozygous or compound heterozygous mutations in GNPTAB gene are associated with the clinical presentation. This is the first study to characterize the underlying genetics of ML among a cohort of Egyptian patients. ML II diagnosis established by clinical assessment, biochemical evaluation of enzymes, electron microscopy examination of gingival inclusion bodies, and molecular study of GNPTAB gene using targeted next-generation sequencing panel in 8 patients form 8 unrelated Egyptian families. Results Sequencing revealed 3 mutations in GNPTAB gene; 1 novel frame-shift mutation in exon 19 (c.3488_3488delC) and 2 previously reported mutations (c.1759C>T in exon 13 and c.3503_3504delTC in exon 19). All patients were homozygous for their corresponding mutations and the parents were consanguineous. Conclusions According to the established quaternary diagnostic scheme, ML II was the final diagnosis in eight patients. The most common mutation was the frame shift c.3503_3504delTC mutation, found in 5 patients and associated with a severe phenotype.
first_indexed 2024-04-24T08:23:33Z
format Article
id doaj.art-61c613f793f842c38196da2d5c2520e0
institution Directory Open Access Journal
issn 2090-5920
language English
last_indexed 2024-04-24T08:23:33Z
publishDate 2021-08-01
publisher Elsevier
record_format Article
series Journal of Genetic Engineering and Biotechnology
spelling doaj.art-61c613f793f842c38196da2d5c2520e02024-04-16T23:53:47ZengElsevierJournal of Genetic Engineering and Biotechnology2090-59202021-08-0119111010.1186/s43141-021-00204-4Quaternary diagnostics scheme for mucolipidosis II and detection of novel mutation in GNPTAB geneMona L. Essawi0Ekram M. Fateen1Hanan A. Atia2Noura R. Eissa3Eman H. Aboul-Ezz4Mona M. Ibrahim5Heba A. Hassan6Samia A. Temtamy7Department of Medical Molecular Genetics, Division of Human Genetics and Genome ResearchDepartment of Medical Molecular Genetics, Division of Human Genetics and Genome ResearchDepartment of Pharmacology and Toxicology, College of Pharmacy, Hail UniversityDepartment of Medical Molecular Genetics, Division of Human Genetics and Genome ResearchNational Research CentreNational Research CentreDepartment of Medical Molecular Genetics, Division of Human Genetics and Genome ResearchNational Research CentreAbstract Background Mucolipidosis II (ML II α/β) is an inherited lysosomal storage disorder caused by deficiency of GlcNAc-phosphotransferase enzyme and results in mis-targeting of multiple lysosomal enzymes. Affected patients are characterized by skeletal deformities and developmental delay. Homozygous or compound heterozygous mutations in GNPTAB gene are associated with the clinical presentation. This is the first study to characterize the underlying genetics of ML among a cohort of Egyptian patients. ML II diagnosis established by clinical assessment, biochemical evaluation of enzymes, electron microscopy examination of gingival inclusion bodies, and molecular study of GNPTAB gene using targeted next-generation sequencing panel in 8 patients form 8 unrelated Egyptian families. Results Sequencing revealed 3 mutations in GNPTAB gene; 1 novel frame-shift mutation in exon 19 (c.3488_3488delC) and 2 previously reported mutations (c.1759C>T in exon 13 and c.3503_3504delTC in exon 19). All patients were homozygous for their corresponding mutations and the parents were consanguineous. Conclusions According to the established quaternary diagnostic scheme, ML II was the final diagnosis in eight patients. The most common mutation was the frame shift c.3503_3504delTC mutation, found in 5 patients and associated with a severe phenotype.https://doi.org/10.1186/s43141-021-00204-4MucolipidosisGNPTAB geneNGSML IIEgyptianMutations
spellingShingle Mona L. Essawi
Ekram M. Fateen
Hanan A. Atia
Noura R. Eissa
Eman H. Aboul-Ezz
Mona M. Ibrahim
Heba A. Hassan
Samia A. Temtamy
Quaternary diagnostics scheme for mucolipidosis II and detection of novel mutation in GNPTAB gene
Journal of Genetic Engineering and Biotechnology
Mucolipidosis
GNPTAB gene
NGS
ML II
Egyptian
Mutations
title Quaternary diagnostics scheme for mucolipidosis II and detection of novel mutation in GNPTAB gene
title_full Quaternary diagnostics scheme for mucolipidosis II and detection of novel mutation in GNPTAB gene
title_fullStr Quaternary diagnostics scheme for mucolipidosis II and detection of novel mutation in GNPTAB gene
title_full_unstemmed Quaternary diagnostics scheme for mucolipidosis II and detection of novel mutation in GNPTAB gene
title_short Quaternary diagnostics scheme for mucolipidosis II and detection of novel mutation in GNPTAB gene
title_sort quaternary diagnostics scheme for mucolipidosis ii and detection of novel mutation in gnptab gene
topic Mucolipidosis
GNPTAB gene
NGS
ML II
Egyptian
Mutations
url https://doi.org/10.1186/s43141-021-00204-4
work_keys_str_mv AT monalessawi quaternarydiagnosticsschemeformucolipidosisiianddetectionofnovelmutationingnptabgene
AT ekrammfateen quaternarydiagnosticsschemeformucolipidosisiianddetectionofnovelmutationingnptabgene
AT hananaatia quaternarydiagnosticsschemeformucolipidosisiianddetectionofnovelmutationingnptabgene
AT nourareissa quaternarydiagnosticsschemeformucolipidosisiianddetectionofnovelmutationingnptabgene
AT emanhaboulezz quaternarydiagnosticsschemeformucolipidosisiianddetectionofnovelmutationingnptabgene
AT monamibrahim quaternarydiagnosticsschemeformucolipidosisiianddetectionofnovelmutationingnptabgene
AT hebaahassan quaternarydiagnosticsschemeformucolipidosisiianddetectionofnovelmutationingnptabgene
AT samiaatemtamy quaternarydiagnosticsschemeformucolipidosisiianddetectionofnovelmutationingnptabgene